Cogent Biosciences Inc (COGT)
Healthcare
Biotechnology
38.90 $
-5.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Cogent Biosciences Inc (COGT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -264 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 18 | -19 | -26 | -32 | -42 | -36 | -59 | -119 | -154 | -208 | -264 | |
| 0.2 | 0.8 | 1.2 | 1.3 | 1.3 | 0.7 | 0.1 | 5.9 | 3.6 | 4.4 | 4.6 | |
| 0.2 | 1.0 | 1.3 | 3.1 | 3.2 | 6.0 | 12 | 18 | 31 | 40 | 46 | |
| – | – | – | – | 3.1 | 44 | 12 | 18 | – | – | – | |
| 24 | -2.3 | -2.9 | -2.2 | -14 | -5.3 | 2.0 | 0.8 | 11 | 12 | 8.0 | |
| 2.0 | 3.3 | 0.9 | 0.5 | 0.0 | 0.3 | 1.7 | 6.9 | 2.8 | 0.6 | 1.6 | |
| -3.2 | -30 | 14 | -11 | 23 | 8.4 | -1.7 | -125 | -98 | 38 | -400 | |
| – | – | – | – | – | 124 | 0.1 | 1.6 | – | – | – | |
| – | – | – | – | – | – | – | – | 0.0 | 0.0 | 218 | |
| 71 | 0.0 | -0.7 | 70 | 0.1 | 232 | 38 | 164 | 164 | 214 | 878 | |
| 85 | -49 | -13 | 27 | -18 | 205 | -23 | -80 | -88 | 45 | 214 | |
| 16 | -22 | -27 | -33 | -42 | -36 | -60 | -126 | -156 | -208 | -266 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.